Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: A systematic review

BMJ Open

Volumn 4, Issue 7, 2014, Pages

  Dzudie, Anastase ^a,b   Kengne, Andre Pascal ^b,c   Thienemann, Friedrich ^b,d   Sliwa, Karen ^b,c,d  

^a DOUALA GENERAL HOSPITAL   (Cameroon)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CARDIOVASCULAR MORTALITY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART DISEASE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LEFT HEART DISEASE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; PREDICTOR VARIABLE; PREVALENCE; PULMONARY HYPERTENSION; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC DYSFUNCTION; COMPLICATION; DISEASE MANAGEMENT; EPIDEMIOLOGY; EUROPE; HYPERTENSION, PULMONARY; MORTALITY; SURVIVAL RATE; TRENDS;

DISEASE MANAGEMENT; EUROPE; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPERTENSION, PULMONARY; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84904255046     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-004843     Document Type: Review

References (57)

1. Fang JC, DeMarco T, Givertz MM, et al. World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult - a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2012;31:913-33.
2. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D34-41.
3. Guazzi M, Borlaug BA. Pulmonary hypertension due to left heart disease. Circulation 2012;126:975-90.
4. Haddad F, Kudelko K, Mercier O, et al. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies. Prog Cardiovasc Dis 2011;54:154-67.
5. Segers VF, Brutsaert DL, De Keulenaer GW. Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction: pathophysiology and natural history. Curr Opin Cardiol 2012;27:273-80.
6. Vachiery JL, Adir Y, Barbera JA, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 2013;62(25 Suppl):D100-8.
7. Parker MW, Mittleman MA, Waksmonski CA, et al. Pulmonary hypertension and long-term mortality in aortic and mitral regurgitation. Am J Med 2010;123:1043-8.
8. Adhyapak SM. Effect of right ventricular function and pulmonary pressures on heart failure prognosis. Prev Cardiol 2010;13:72-7.
9. Merlos P, Nunez J, Sanchis J, et al. Echocardiographic estimation of pulmonary arterial systolic pressure in acute heart failure. Prognostic implications. Eur J Intern Med 2013;24:562-7.
10. Agarwal R, Shah SJ, Foreman AJ, et al. Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction. J Heart Lung Transplant 2012;31:467-77.
11. Agarwal R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transplant 2012;27:3908-14.
12. Aronson D, Eitan A, Dragu R, et al. Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure. Circ Heart Fail 2011;4:644-50.
13. Bursi F, McNallan SM, Redfield MM, et al. Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol 2012;59:222-31.
14. Strange G, Playford D, Stewart S, et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 2012;98:1805-11.
15. Mutlak D, Aronson D, Carasso S, et al. Frequency, determinants and outcome of pulmonary hypertension in patients with aortic valve stenosis. Am J Med Sci 2012;343:397-401.
16. Tatebe S, Fukumoto Y, Sugimura K, et al. Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease. Circ J 2012;76:1235-44.
17. Stern J, Heist EK, Murray L, et al. Elevated estimated pulmonary artery systolic pressure is associated with an adverse clinical outcome in patients receiving cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007;30:603-7. (Pubitemid 46653149)
18. Lee WT, Peacock AJ, Johnson MK. The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension. Eur Respir J 2010;36:1294-301.
19. Moller JE, Hillis GS, Oh JK, et al. Prognostic importance of secondary pulmonary hypertension after acute myocardial infarction. Am J Cardiol 2005;96:199-203. (Pubitemid 40978573)
20. Cappola TP, Felker GM, Kao WH, et al. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation 2002;105:1663-8. (Pubitemid 34298609)
21. Szwejkowski BR, Elder DH, Shearer F, et al. Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study. Eur J Heart Fail 2012;14:162-7.
22. Abramson SV, Burke JF, Kelly JJ Jr, et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992;116:888-95. (Pubitemid 23034779)
23. Kjaergaard J, Akkan D, Iversen KK, et al. Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol 2007;99:1146-50. (Pubitemid 46578202)
24. Shalaby A, Voigt A, El-Saed A, et al. Usefulness of Pulmonary Artery Pressure by Echocardiography to Predict Outcome in Patients Receiving Cardiac Resynchronization Therapy Heart Failure. Am J Cardiol 2008;101:238-41.
25. Damy T, Goode KM, Kallvikbacka-Bennett A, et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J 2010;31:2280-90.
26. Ristow B, Ali S, Ren X, et al. Elevated pulmonary artery pressure by Doppler echocardiography predicts hospitalization for heart failure and mortality in ambulatory stable coronary artery disease: the Heart and Soul Study. J Am Coll Cardiol 2007;49:43-9. (Pubitemid 46026900)
27. Grigioni F, Potena L, Galie N, et al. Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. J Heart Lung Transplant 2006;25:1241-6. (Pubitemid 44528289)
28. Levine TB, Levine AB, Goldberg D, et al. Impact of medical therapy on pulmonary hypertension in patients with congestive heart failure awaiting cardiac transplantation. Am J Cardiol 1996;78:440-3. (Pubitemid 26277025)
29. Lam CSP, Roger VL, Rodeheffer RJ, et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009;53:1119-26.
30. Khush KK, Tasissa G, Butler J, et al. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: Analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J 2009;157:1026-34.
31. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001;37:183-8. (Pubitemid 32051736)
32. Wang D, Han Y, Zang H, et al. Prognostic effects of pulmonary hypertension in patients undergoing cardiac resynchronization therapy. J Thorac Dis 2010;2:71-5.
33. Ghio S, Temporelli PL, Klersy C, et al. Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. Eur J Heart Fail 2013;15:408-14.
34. Naidoo DP, Mitha AS, Vythilingum S, et al. Pulmonary hypertension in aortic regurgitation: early surgical outcome. Q J Med 1991;80:589-95.
35. Fawzy ME, Hassan W, Stefadouros M, et al. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis 2004;13:942-7; discussion 47-8.
36. Roselli EE, Abdel Azim A, Houghtaling PL, et al. Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: implications for transcatheter aortic valve replacement. J Thorac Cardiovasc Surg 2012;144:1067-74 e2.
37. Melby SJ, Moon MR, Lindman BR, et al. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 2011;141:1424-30.
38. Le Tourneau T, Richardson M, Juthier F, et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 2010;96:1311-17.
39. Kainuma S, Taniguchi K, Toda K, et al. Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation. J Thorac Cardiovasc Surg 2011;142:783-92.
40. Barbieri A, Bursi F, Grigioni F, et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 2011;32:751-9.
41. Manners JM, Monro JL, Ross JK. Pulmonary hypertension in mitral valve disease: 56 surgical patients reviewed. Thorax 1977;32:691-6.
42. Malouf JF, Enriquez-Sarano M, Pellikka PA, et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol 2002;40:789-95. (Pubitemid 34925628)
43. Khandhar S, Varadarajan P, Turk R, et al. Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension. Ann Thorac Surg 2009;88:752-6.
44. Zuern CS, Eick C, Rizas K, et al. Prognostic value of mild-to-moderate pulmonary hypertension in patients with severe aortic valve stenosis undergoing aortic valve replacement. Clin Res Cardiol 2012;101:81-8.
45. Ben-Dor I, Goldstein SA, Pichard AD, et al. Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol 2011;107:1046-51.
46. Yang C, Li D, Mennett R, et al. The impact of pulmonary hypertension on outcomes of patients with low left ventricular ejection fraction: a propensity analysis. J Heart Valve Dis 2012;21:767-73.
47. Nozohoor S, Hyllen S, Meurling C, et al. Prognostic value of pulmonary hypertension in patients undergoing surgery for degenerative mitral valve disease with leaflet prolapse. J Card Surg 2012;27:668-75.
48. Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease. Natural history and results of surgery. Br Heart J 1975;37:74-8.
49. Ghoreishi M, Evans CF, DeFilippi CR, et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 2011;142:1439-52.
50. Cam A, Goel SS, Agarwal S, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2011;142:800-8.
51. Pai RG, Varadarajan P, Kapoor N, et al. Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg 2007;84:80-5. (Pubitemid 46921129)
52. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427-37. (Pubitemid 46768164)
53. de Jonge RC, van Furth AM, Wassenaar M, et al. Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infect Dis 2010;10:232.
54. Vahanian A, Alfieri O, Andreotti F, et al. [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol (Rome) 2013;14:167-214.
55. Goldstone AB, Chikwe J, Pinney SP, et al. Incidence, epidemiology, and prognosis of residual pulmonary hypertension after mitral valve repair for degenerative mitral regurgitation. Am J Cardiol 2011;107:755-60.
56. Damasceno A, Mayosi BM, Sani M, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med 2012;172:1386-94.
57. Janda S, Shahidi N, Gin K, et al. Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart 2011;97:612-22.